Akorn Inc. has voluntarily recalled approximately 153 tubes of Desoximetasone Ointment USP, 0.25%, including 15g and 60g sizes. The medication is being recalled because it failed stability specifications due to issues with homogeneity and phase separation, meaning the ingredients in the ointment have separated and are no longer mixed correctly. Consumers should contact their healthcare provider or pharmacist regarding the use of this product and return any remaining ointment to the place of purchase for a refund.
When the ointment separates or loses its homogeneity, the active medication may not be distributed evenly throughout the tube. This can result in the patient receiving too much or too little of the drug in a single application, potentially leading to ineffective treatment of the skin condition or an increased risk of localized side effects.
Pharmaceutical refund and medical guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.